CCC completes $427.9M cash + 26M shares acquisition of EvolutionIQ

CCC Intelligent Solutions Holdings Inc.

Total consideration: ~$427.9M cash plus 26.0M shares of CCCS common stock; $300M share repurchase program authorized.
Acquisition funded in part via $225M incremental term loans under amended credit agreement; maturity Sept 2028.
EvolutionIQ is an AI platform for disability and workers' comp claims; expands CCC's market into strategic adjacencies.
10.4M shares of stock consideration subject to vesting/transfer restrictions; resale S-3 to be filed within 5 business days.
Combined platform aims to revolutionize claim resolution with AI-based medical summarization and next best action.

item 1.01 item 2.03 item 3.02 item 8.01 item 7.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.